If you have hypertrophic cardiomyopathy (HCM) and are experiencing symptoms such as shortness of breath, chest pain, ...
A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...
Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...
Hosted on MSN
These New Heart Meds Could Be Game Changers. Here's How to Know If They're Right for You.
NO MATTER HOW diligent you are about regular workouts and smart food choices, bad genes can overpower even the healthiest lifestyle, making heart medication essential. Though many people who come to ...
December 17, 2010 — Dolasetron mesylate (Anzemet; Aventis Pharmaceuticals) should no longer be used for the prevention of chemotherapy-induced nausea and vomiting because of an increased risk for ...
Digital health platform Hello Heart is launching a new suite of medication management tools for people at risk of heart disease, including an AI assistant for heart health. Through a connected blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback